Graft Versus Host Disease (GvHD) Treatment Market Demand, Insights and Forecast up to 2026  Downey Magazine

Out of state ‘dark money’ fueled Colorado’s 2018 election; AG Weiser among beneficiaries despite transparency pledge  Complete Colorado

TransMedics’ Organ Care System (OCS™) Technology Used in First U.S. Adult Human Heart Transplants From DCD Donors  GlobeNewswire

Graft Versus Host Disease (GvHD) Treatment Market Size Estimated to Observe Significant Growth by 2026  News Description

$100K in campaign cash to gov, mayor, county exec is routine business expense, Cor says  syracuse.com

Tarekh Rana is an acclaimed Ajax businessman. Is he also a fugitive crime boss?  Global News

Bristol-Myers Squibb Announces U.S. FDA Breakthrough Therapy Designation for ORENCIA® (abatacept) to Help Prevent Acute Graft-Versus-Host Disease, a Potentially Life-Threatening Complication After Stem Cell Transplant  West Plains Daily Quill

Bristol-Myers Squibb Announces U.S. FDA Breakthrough Therapy Designation for ORENCIA® (abatacept) to Help Prevent Acute Graft-Versus-Host Disease, a Potentially Life-Threatening Complication After Stem Cell Transplant  Business Wire

What’s Going On Dec. 4  Odessa American